FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382631981> ?p ?o ?g. }

• W4382631981 endingPage "e2320960" @default.
• W4382631981 startingPage "e2320960" @default.
• W4382631981 abstract "Importance Electric scooter (e-scooter) use is increasing in France and in many urban environments worldwide. Yet little is known about injuries associated with use of e-scooters. Objective To describe characteristics and outcomes of major trauma involving e-scooters. Design, Setting, and Participants A multicenter cohort study was conducted in France using the national major trauma registry between January 1, 2019, and December 20, 2022. All patients admitted to a participating major trauma center following a road traffic crash (RTC) involving an e-scooter, a bicycle, or a motorbike were included. Exposure Included patients were compared according to the 3 mechanisms. Main Outcomes and Measures The primary outcome was trauma severity as defined by the Injury Severity Score (ISS). Secondary outcomes included the trends of the number of patients per year, a comparison of the RTC epidemiologic factors, injury severity, resources used, and in-hospital outcomes. Results A total of 5233 patients involved in RTCs were admitted (median age, 33 [IQR, 24-48] years; 4629 [88.5%] men; median ISS, 13 [IQR, 8-22]). The population included 229 e-scooter RTCs (4.4%), 4094 motorbike RTCs (78.2%), and 910 bicycle RTCs (17.4%). The number of patients treated following e-scooter RTCs increased by 2.8-fold in 4 years (from 31 in 2019 to 88 in 2022), while bicycle RTCs increased by 1.2-fold and motorbike RTCs decreased by 0.9-fold. At admission, 36.7% of e-scooter users had a blood alcohol content higher than the legal threshold (n = 84) and 22.5% wore a protective helmet (n = 32). Among e-scooter RTCs, 102 patients (45.5%) had an ISS of 16 or higher. This proportion was similar for patients with motorbike RTCs (1557 [39.7%]; P = .10) and bicycle RTCs (411 [47.3%]; P = .69). With a proportion of 25.9% (n = 50), patients with e-scooter RTCs had twice as many severe traumatic brain injuries (Glasgow Coma Scale ≤8) as motorbike RTCs (445 [11.8%]) and a proportion comparable to bicycle RTCs (174 [22.1%]). The mortality of e-scooter RTCs was 9.2% (n = 20), compared with 5.2% (n = 196) ( P = .02) for motorbikes and 10.0% (n = 84) ( P = .82) for bicycles. Conclusions and Relevance The findings of this study suggest that trauma involving e-scooters in France has significantly increased over the past 4 years. These patients presented with injury profiles as severe as those of individuals who experienced bicycle or motorbike RTCs, with a higher proportion of severe traumatic brain injury." @default.
• W4382631981 created "2023-07-01" @default.
• W4382631981 creator A5009935736 @default.
• W4382631981 creator A5010771940 @default.
• W4382631981 creator A5013375587 @default.
• W4382631981 creator A5013729967 @default.
• W4382631981 creator A5028229577 @default.
• W4382631981 creator A5032293357 @default.
• W4382631981 creator A5047979124 @default.
• W4382631981 creator A5056821927 @default.
• W4382631981 creator A5063419310 @default.
• W4382631981 creator A5064875960 @default.
• W4382631981 creator A5065588277 @default.
• W4382631981 creator A5067692511 @default.
• W4382631981 creator A5068979551 @default.
• W4382631981 creator A5070752352 @default.
• W4382631981 creator A5081776524 @default.
• W4382631981 creator A5085042646 @default.
• W4382631981 date "2023-06-30" @default.
• W4382631981 modified "2023-10-18" @default.
• W4382631981 title "Comparison of Injuries Associated With Electric Scooters, Motorbikes, and Bicycles in France, 2019-2022" @default.
• W4382631981 cites W122568889 @default.
• W4382631981 cites W1963999607 @default.
• W4382631981 cites W1985583679 @default.
• W4382631981 cites W2030046027 @default.
• W4382631981 cites W2056208640 @default.
• W4382631981 cites W2777056372 @default.
• W4382631981 cites W2911649669 @default.
• W4382631981 cites W2937420545 @default.
• W4382631981 cites W2965807578 @default.
• W4382631981 cites W2996300032 @default.
• W4382631981 cites W2996974877 @default.
• W4382631981 cites W3027690032 @default.
• W4382631981 cites W3103507636 @default.
• W4382631981 cites W3118967077 @default.
• W4382631981 cites W3120705644 @default.
• W4382631981 cites W3172267848 @default.
• W4382631981 cites W3174130715 @default.
• W4382631981 cites W3188218682 @default.
• W4382631981 cites W3204358555 @default.
• W4382631981 cites W4224293922 @default.
• W4382631981 cites W4226106812 @default.
• W4382631981 cites W4226139437 @default.
• W4382631981 cites W4235215643 @default.
• W4382631981 cites W4237496953 @default.
• W4382631981 cites W4246971015 @default.
• W4382631981 cites W4285719527 @default.
• W4382631981 cites W4293108385 @default.
• W4382631981 cites W4312068386 @default.
• W4382631981 cites W4320301321 @default.
• W4382631981 cites W4361868941 @default.
• W4382631981 doi "https://doi.org/10.1001/jamanetworkopen.2023.20960" @default.
• W4382631981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37389873" @default.
• W4382631981 hasPublicationYear "2023" @default.
• W4382631981 type Work @default.
• W4382631981 citedByCount "0" @default.
• W4382631981 crossrefType "journal-article" @default.
• W4382631981 hasAuthorship W4382631981A5009935736 @default.
• W4382631981 hasAuthorship W4382631981A5010771940 @default.
• W4382631981 hasAuthorship W4382631981A5013375587 @default.
• W4382631981 hasAuthorship W4382631981A5013729967 @default.
• W4382631981 hasAuthorship W4382631981A5028229577 @default.
• W4382631981 hasAuthorship W4382631981A5032293357 @default.
• W4382631981 hasAuthorship W4382631981A5047979124 @default.
• W4382631981 hasAuthorship W4382631981A5056821927 @default.
• W4382631981 hasAuthorship W4382631981A5063419310 @default.
• W4382631981 hasAuthorship W4382631981A5064875960 @default.
• W4382631981 hasAuthorship W4382631981A5065588277 @default.
• W4382631981 hasAuthorship W4382631981A5067692511 @default.
• W4382631981 hasAuthorship W4382631981A5068979551 @default.
• W4382631981 hasAuthorship W4382631981A5070752352 @default.
• W4382631981 hasAuthorship W4382631981A5081776524 @default.
• W4382631981 hasAuthorship W4382631981A5085042646 @default.
• W4382631981 hasBestOaLocation W43826319811 @default.
• W4382631981 hasConcept C126322002 @default.
• W4382631981 hasConcept C141071460 @default.
• W4382631981 hasConcept C142724271 @default.
• W4382631981 hasConcept C167135981 @default.
• W4382631981 hasConcept C187155963 @default.
• W4382631981 hasConcept C190385971 @default.
• W4382631981 hasConcept C194828623 @default.
• W4382631981 hasConcept C201903717 @default.
• W4382631981 hasConcept C2780110798 @default.
• W4382631981 hasConcept C2908647359 @default.
• W4382631981 hasConcept C3017944768 @default.
• W4382631981 hasConcept C71924100 @default.
• W4382631981 hasConcept C72563966 @default.
• W4382631981 hasConcept C85004164 @default.
• W4382631981 hasConcept C99454951 @default.
• W4382631981 hasConceptScore W4382631981C126322002 @default.
• W4382631981 hasConceptScore W4382631981C141071460 @default.
• W4382631981 hasConceptScore W4382631981C142724271 @default.
• W4382631981 hasConceptScore W4382631981C167135981 @default.
• W4382631981 hasConceptScore W4382631981C187155963 @default.
• W4382631981 hasConceptScore W4382631981C190385971 @default.
• W4382631981 hasConceptScore W4382631981C194828623 @default.
• W4382631981 hasConceptScore W4382631981C201903717 @default.
• W4382631981 hasConceptScore W4382631981C2780110798 @default.

• next